TP53 and neoplasm: Moreover, the univariate logistic regression of KNSTRN expression also suggested a close relationship between KNSTRN and clinical characteristics., including T stage [odds ratio (OR) = 1.04 (1.02-1.07), P < 0.001], N stage [OR = 1.02 (1.01-1.04), P = 0.010], clinical stage [OR = 1.03 (1.01-1.05), P = 0.003)], tumor status [OR = 1.03 (1.01-1.05), P = 0.002], outcome of the primary therapy [OR = 1.04 (1.02-1.07), P < 0.001], and TP53 mutation [OR = 1.04 (1.02-1.06), P < 0.001] (Table 2).